CRDF:NASDAQ, Cardiff Oncology, Inc.

Why CRDF stock rose on November 16

Cardiff Oncology, Inc. rose 16.4% on Monday, November 16, 2026, on 25,841,300 shares, 25 times its average daily volume. The headline around the move:

CRDF stock overview

Cardiff Oncology, Inc. (CRDF:NASDAQ) closed at $0.853 on November 20, 2026, down 4.46% on the day. The stock trades 74.2% below its 52-week high of $3.31 and 20.1% above its 52-week low of $0.710. Over the past year, it lost 58.0%. Cardiff Oncology, Inc. is part of the Health Care sector.

Key figures

Price
$0.853
Day change
-4.46%
Volume
520,597
Average volume
1,015,878
Market cap
66M+
52-week range
$0.710 – $3.31
50-day average
$1.02
200-day average
$1.33

Price action over the past year

In 252 trading sessions since November 20, 2025, CRDF closed higher on 113 days (45%). Its best day was November 16, 2026 (+16.44%) and its worst was July 15, 2026 (-32.06%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

CRDF news

About Cardiff Oncology, Inc.

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Similar stocks

Find more stocks like CRDF with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.